medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Number 1

<< Back Next >>

Ann Hepatol 2019; 18 (1)

Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay

Mainardi V, Rando K, Valverde M, Olivari D, Castelli J, Rey G, Gerona S

Language: English
References: 27
Page: 187-192
PDF size: 189.89 Kb.


ABSTRACT

Introduction and aim. Wilson’s disease (WD) is an uncommon cause of acute liver failure (ALF). Our aim was to describe clinical features, diagnostic findings, treatments, and outcomes of patients with ALF due to WD. Material and methods. Retrospective medical record reviews of all patients with ALF due to WD in eight years in Uruguay. Results. WD was the cause of six (15%) of thirty-nine ALF cases. All patients were females, with a mean age of 18 years. Four patients presented with hyperacute liver failure and two with acute failure. Jaundice was the main complaint of all patients. Mean total bilirubin (TB), alkaline phosphatase (AP), AST, and ALT were 27.5 mg/dL, 45.5 IU/l, 156 IU/L, and 51 IU/L, respectively. Ceruloplasmin levels were low in four patients, urinary cooper was high in four, and two had Kayser-Fleischer rings. All patients had Coombs-negative hemolytic anemia, acute kidney injury, histochemical identifiable copper, and advanced fibrosis on liver histology. The average MELD score was 36. All patients were treated with d-penicillamine and listed for urgent liver transplantation (LT). Prometheus® was performed in one patient. Three patients died: two without LT and one after LT. Three patients survived: one without LT (New Wilson Index ‹ 11) and two with LT. The referral time to the program and the total time (referral plus waiting list time) were longer for non-survivors than for survivors (14 vs. 3 days and 23 vs. 8 respectively). Conclusion. All cases had typical clinical, analytical and histopathology characteristics. Early referral was determinant of prognosis.


REFERENCES

  1. Frydman M. Genetic aspects of Wilson’s disease. J Gastroenterol Hepatol 1990; 5: 483-90.

  2. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 15: 947-55.

  3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol 2012; 56: 671-85.

  4. Mendizabal M, Marciano S, Videla MG, Anders M, Zerega A, Balderramo DC, Chan D, et al. Changing etiologies and outcomes of acute liver failure: Perspectives from 6 transplant centers in Argentina. Liver Transplant 2014; 20: 483-9.

  5. Scheinberg IH. Wilson’s disease. J Rheumatol Suppl 1981; 7: 90-3.

  6. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: A cohort study. Gut 2007; 56: 115-20.

  7. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011. Hepatology 2012; 55: 965-7.

  8. Roberts EA, Schilsky ML. AASLD practice guidelines: Diagnosis and treatment of Wilson disease: An update. Hepatology 2008; 47: 2089-111.

  9. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129-34.

  10. Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O’Grady J, Mowat, Mieli-Vergani G, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson’s disease from other fulminant liver failure. Hepatology 1992; 16: 1206-11.

  11. Eisenbach C, Sieg O, Stremmel W, Encke J, Merle U. Diagnos tic criteria for acute liver failure due to Wilson Disease. World J Gastroenterol 2007; 13: 1711-4.

  12. Korman J, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH, Fontana RJ, et al. Screening for Wilson disease in acute liver failure: A comparison of currently available diagnostic tests. Hepatology 2008; 48: 1167-74.

  13. Catana AM, Medici V. Liver transplantation for Wilson disease. World J Hepatol 2012; 4: 5-10.

  14. Kido J, Matsumoto S, Momosaki K, Sakamoto R, Mitsubishi H, Inomata Y, Endo F, et al. Plasma Exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation. Hepatol Res 2017; 47: 359-63.

  15. Reynolds HV, Talekar CR, Bellapart J, Leggett BA, Boots RJ. Copper removal strategies for Wilson’s disease crisis in ICU. Anaesth Intensive Care 2014; 42: 253-7.

  16. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson’s disease: Clinical presentation and use of prognostic index. Gut 1986; 27: 1377-81.

  17. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson’s disease in children: 37- year experience and revised King’s score for liver transplantation. Liver Transplant 2005; 11: 441-8.

  18. Uruguay en cifras 2014. Instituto Nacional de Estadística. http//www.ine.gub.uy

  19. O’Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.

  20. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.

  21. Rivera-Penera T, Moreno J, Skaff C, McDiarmid S, Vargas J, Ament ME. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr 1997; 24: 128-34.

  22. Sturm E, Lexmond WS, Verkade HJ. Pediatric acute liver failure: variations in referral timing are associated with disease subtypes. Eur J Pediatr 2015; 174: 169-75.

  23. European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017; 66: 1047-81.

  24. Park SJ, Lim YS, Hwang S, Heo NY, Lee HC, Suh DJ, Yu E, Lee SG. Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area. Hepatology 2010; 51: 903-11.

  25. Liu CL, Fan ST, Lo CM, Wei WI, Yong BH, Lai CL, Wong J. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation 2003; 76: 1174-9.

  26. Everhart JE, Lombardero M, Detre KM, Zetterman RK, Wiesner RH, Lake JR, Hoofnagle JH. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997; 64: 1300-6.

  27. Yuan D, Liu F, Wei Y-G, Li B, Yan LN, Wen TF, Zhao JC, et al. Adult-to-adult living donor liver transplantation for acute liver failure in China. World J Gastroenterol 2012; 18: 7234-41.




2020     |     www.medigraphic.com